Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ibuprofen
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Advil Extra Strength 400mg tablets
1001010J0CEABAE
|
Advil | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Ibuprofen 200mg tablets
1001010J0CJAAAD
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Joint Pain 200mg tablets
1001010J0CJADAD
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin LiquiFast 200mg effervescent tablets
1001010J0CJAEBP
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin LiquiFast 400mg capsules
1001010J0CJACAU
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Period Pain Relief 200mg capsules
1001010J0CJAFAA
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Anadin Ultra 200mg capsules
1001010J0CJABAA
|
Anadin (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrofen 200 tablets
1001010J0B1ADAD
|
Arthrofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrofen 400 tablets
1001010J0B1AEAE
|
Arthrofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrofen 600 tablets
1001010J0B1AFAF
|
Arthrofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Bell's Back & Muscle Pain Relief 200mg capsules
1001010J0DMABAA
|
Bell's (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Bell's Children's Pain & Fever Relief 100mg/5ml susp
1001010J0DMAABH
|
Bell's (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen 3 Months Plus 100mg/5ml susp strawberry
1001010J0CFACBH
|
Boots ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen 6 Months Plus 100mg/5ml susp strawberry
1001010J0CFABBH
|
Boots ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen and Codeine 200mg/12.8mg tablets
1001010J0CFADAY
|
Boots ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen Long Lasting 200mg capsules
1001010J0CFAEBA
|
Boots ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Boots Ibuprofen Max Strength 10% gel
1003020P0BPADAI
|
Boots (Topical ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Brufen 200mg tablets
1001010J0BCAAAD
|
Brufen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Calprofen 100mg/5ml oral suspension 5ml sachets
1001010J0DBACBM
|
Calprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Calprofen 100mg/5ml oral suspension paediatric
1001010J0DBABBH
|
Calprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Care Ibuprofen for Children 100mg/5ml oral suspension
1001010J0CUABBH
|
Care Ibuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Codafen Continus tablets
1001010J0B8AAAR
|
Codafen Continus | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cuprofen 200mg tablets
1001010J0BMAAAD
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cuprofen 5% gel
1003020P0BJAAAC
|
Cuprofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Cuprofen for Children 100mg/5ml oral suspension
1001010J0BMADBH
|
Cuprofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.